Résumé
Researches on drug-eluting stents are now focusing on three main aspects: the stent materials, the coating matrix material and the selection, adhesion and controlled release of the biological agents. The current development progresses of the coating materials, their characteristics, and the coating method for metallic stents are reviewed in this paper.
Sujets)
Humains , Matériaux revêtus, biocompatibles , Resténose coronaire , Vecteurs de médicaments , Systèmes de délivrance de médicaments , Polymères , Chimie , EndoprothèsesRésumé
In order to prove the feasibility of preparation of the drug-incorporated stent by immersing stent wires in the monoclonal antibody (mAb) solution, fluorescence stain and image analysis were used to evaluate the L-PLA-coated stent. Absorption was measured using a radioisotope technique after preparing the mAb-incorporated stent, and the absorption curve was determined from the absorption data. In an in vitro perfusion circuit, the antibody was eluted from the stent matrices, and the related influence factors were evaluated based on the release data.